Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
European Low and Intermediate Risk Neuroblastoma Protocol

ganglioneuroblastoma nodular patients in order to improve the EFS registered in the previous SIOPEN study; improve the EFS (Event Free Survival) of MYCN (V-Myc myelocytomatosis viral related oncogene, NB

  • 125 views
  • 23 Jan, 2021
  • 82 locations
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

This is a randomized study of the European SIOP Neuroblastoma Group (SIOPEN) in high-risk neuroblastoma (stages 2, 3, 4 and 4s MYCN-amplified neuroblastoma, stage 4 MYCN non amplified > 12

colony stimulating factor
busulfan
high-risk neuroblastoma
mycn protein
vincristine
  • 308 views
  • 26 Jan, 2021
  • 126 locations
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)

This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.

  • 17 views
  • 12 May, 2022
  • 17 locations
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

metastasis
mycn protein
cancer
ganglioneuroblastoma
bone marrow procedure
  • 214 views
  • 09 Apr, 2022
  • 154 locations